Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : iPSC-EC
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Recipient : Cellino
Deal Size : Undisclosed
Deal Type : Partnership
Cellino and Karis Bio Develop Nebula-Powered iPSC Therapy for Heart Disease
Details : The partnership aims to industrialize the world’s first clinical-stage autologous iPSC-derived cell therapy for peripheral artery disease (PAD) and coronary artery disease (CAD).
Product Name : iPSC-EC
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
April 15, 2025
Lead Product(s) : iPSC-EC
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Recipient : Cellino
Deal Size : Undisclosed
Deal Type : Partnership